1 / 36

ENTERPRISE GROUP LABIOFAM

ENTERPRISE GROUP LABIOFAM. Labiofam.

nirav
Download Presentation

ENTERPRISE GROUP LABIOFAM

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ENTERPRISEGROUPLABIOFAM

  2. Labiofam Impelled by the need appeared during the 60’s caused by the deprive of vaccines and medicines and in order to achieve the necessary development of the live stock as an strategy of the country to guarantee the people’s nourishing, emerges the Cuban Industry of Veterinary Vaccines and Medicines, which during its evolution became the Entrepreneurial Group LABIOFAM. As times evolved and in order to face the changes in the world economy and the ups and downs of the international market, it is designed an strategy of diversification, developing the foundations for other productions as Biological Pesticides to control epidemics and sickness, Hygiene Products, Dietetic Supplements of natural origin for and Food.

  3. Labiofam The actual operations of the Group are directed to veterinary vaccines and medicines that includes a wide variety of Biologics and Pharmaceuticals guaranteeing 97% of the national consumption of veterinary products. LABIOFAM integrates, as all the Cuban Production – Research – Development Centres to other entities of the same sphere and Universities, integration which magnifies its research capacity.

  4. Production of biological and pharmaceutical in order to guarantee the animal health of our mass in every sectors, state owned, cooperative and private. Missión

  5. General Structure PRESIDENCY LABIOFAM. SA Vice Presidency Ejecutive Vice Presidency Ejecutive Vice Presidency of Production Vice Presidency Importation 8 Production Enterprises Vice Presidency of Economy Vice Presidency Economy 5 Services Enterprises Vice Presidency of Quality Comercialization Abroad Vice Presidency of Human Resources Join Business 14 Provincial Branches

  6. Regulations LABIOFAM develops its biological processes fullfiling the regulations and legislation existing in Cuba, acting as regulatory authorities the National Centre of Biological Safety and the National Veterinary Centre of State Control. The regulations and legislation are the following: • Law Decree No. 190 of Biological Safety • Law Decree No. 137 about Veterinary Medicine • Law No. 81 - Environment • Law Decree 200 Contraventions on the Environment • Law 13 Work Protection and Hygiene • Regulations on Biological Diversity • Regulations for Granting the Authorisations on Biological Safety • Rules of the Evaluation Process of Environmental Impact • Rules for the State Environment Inspection

  7. Resolution 130/95 • Resolution 111/96 • Resolution 23/97 • Resolution 42/99 • Resolution 77/99 • Resolution 87/99 • Resolution 8/00 • Resolution 76/00 • Resolution 190/01 • Resolution 31/02 Regulations

  8. Production Enterprises • Bacterial Products Laboratories. • Virology Products Laboratories. • Pharmaceutical and Inyectable Products Laboratories. • Hemoderivatives, Serum and Bioteries Laboratories. • Dietetic Suplements Laboratories. • Pharmaceutical and Chemical Laboratories. • Camaguey Natural Products Laboratories. • Plastic Containers Producer.

  9. Service Enterprises • Construction, Maintenance and Projects. • General Service. • Emplayer. • Quality Control Laboratories. • Farms

  10. Comercial Company • 14 Branches in the National Territory . • Commercial operations in 27 countries. • Join Business with National an Foreign companies.

  11. of Labiofam Productions

  12. Veterinary Pharmaceuticals Antibiotics-Anaesthetics, Sedatives and Hypnotics External and Internal Antiparasitics Antiseptics, Disinfectants, Astringents of Specific Action Anti histaminic y Diuretics Dissolvers Hormones Diagnostic Media Laxatives Chemotherapeutics Serums and Nutritional Vitamins

  13. Biologic Immunisers Viral Vaccines Bacterial Vaccines Anti toxins Stimulant Biogenics Hemoderivatives Hormones Diagnostic Media

  14. VIRAL VACCINES Avian Infectious Bronchitis Newcastle inactivated La Sota Strain Newcastle La Sota Strain Gumboro Avian Pox Avian Encephalomyelitis Hog Cholera Aujeszkyinactivated Viral Encephalomyocarditis (EMC) EMC – Aujeszkyinactivated EMC - Aujeszky – Leptospirainactivated Contagious Ecthyma Equine Encephalomyelitis Eastern Type Canine Distemper Canine Hepatitis Canine Distemper - Hepatitis Canine Distemper - Hepatitis + Leptospira Biologic Products

  15. BACTERIAL VACCINES Brucella Abortus Strain 19 Bovine Hemorrhagic Septicaemiainactivated Salmonella dublin typhimurium choleraesuisinactivated Salmonella dublin typhimuriuminactivated Swine Erysipelas Swine Colibacilosisinactivated Rabbit Hemorrhagic Septicaemiainactivated Neumo - S – Suis Avian Cholerainactivated IHBBinactivated Blackleg inactivated Polyvalent Leptospirainactivated Tetanic Toxoid

  16. ANTITOXINS Tetánic HORMONES Seric Gonadotropine Estradiol Benzoate Progesterone Oxipresine

  17. DIAGNOSTIC MEDIA Equine Infectious Anaemia Antigen Equine Infectious Anaemia Antiserum Bengala Rose B.abortus Antigen Ring Test B. abortus Antigen Slow Test B. abortus Antigen RFC Brucella abortus Antigen Bovine Tuberculin Avian Tuberculin Kit Newcastle Lyophilised Complement B. abortus Positive Control Serum B. abortus Negative Control Serum Haemolysin Antiestrome Hemolisin

  18. % of Animals Free of Brucellocis Cases

  19. Results in Cuba of the Newcastle Vaccine Results in Cuba of the Newcastle Vaccine 1 0,8 0,6 0,4 Cases 0,2 0 1985 1987 1989 1991 1993 1995 1997 1999 2001 2002 2003 Years

  20. Results in Cuba of the E.E.E. Vaccine 400 200 Cases Cases 0 1970 1975 1980 1985 1990 1995 2000 2002 2003 Years Results in Cuba of the E.E.E. Vaccine

  21. Results in Cuba of the Avian Pox Vaccine Results in Cuba of the Avian Pox Vaccine 15000 10000 Cases 5000 0 1991 1992 1993 1994 1995 1997 1998 2002 2003 1999 1985 1987 1989 1990 2000 2001 Years Cases

  22. Results in Cuba of the Avian Infectious Bronchitis Vaccine Results in Cuba of the Avian Infectious Bronchitis Vaccine 100000 80000 60000 Cases 40000 20000 0 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 Years Cases

  23. Results in Cuba of the Avian Encephalomyelitis Vaccine Results in Cuba of the Avian Encephalomyelitis Vaccine 60000 50000 40000 Cases 30000 20000 10000 0 1991 2002 1985 1986 1987 1988 1989 1990 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2003 Years Cases

  24. Results in Cuba of the Bovine Tuberculosis Results in Cuba of the Bovine Tuberculosis 5 4 3 Cases 2 1 0 1996 1997 1998 1999 2000 2001 2002 2003 Years Cases

  25. Dietetic Supplements Natural Products Bactivec Griselesf Biorat Biologic Pesticides Food Probiotics

  26. Disinfectants Algaecide Detergents Bleach Disincrustant Scourers Natural Repellent Odorizers Shampoo Hand and Bath Gel Cologne Hygiene Products Different size, material and shapes. Plastic Containers

  27. Commerce Labiofam S. A. trades the productions and services, locally and abroad, generated by the entities conforming the Group and supplies environmental sanitation.

  28. Countries in which trade developed • Latin America: • Bolivia, Brazil, El Salvador, Chile, Colombia, Costa Rica, Ecuador, Guatemala, Honduras, Nicaragua, Panama, Paraguay, Peru, Dominican R. Venezuela, México y Argentina. • Asia: • Cambodia, China, Philippines, Laos, Sri Lanka and Vietnam. • Africa: • Angola, Gambia, Ruwanda,Tanzania, Nigeria, Mozambique, Gabon, Guinea Equatorial, Sao Tomé y Ghana . • Europe: • Spain, U.K., Rumania and Sweden.

  29. In parallel with trading, it is also developed the concretion of join business of different nature with national and foreign Companies, from Join Ventures to Cooperated Productions and Productions Contracts.

  30. As antecedent of the activities in support of human health, LABIOFAM has contributed in the control of different epidemics: Bubonic plague Peru 1994 BIORAT Leptospira Nicaragua 1995 BIORAT Dengue Nicaragua 1996-97 Bactivec Murinus Typhus Mexico 1997 BIORAT Hemorrhagic Fever Bolivia 1998 BIORAT Malaria Brazil 1999/2002 Griselesf Malaria Angola 2001/2002 Griselesf Hanta Virus Chile 2002 BIORAT Dengue Cuba 2002 Bactivec Malaria Gambia 2002 Griselesf In the State of Amazonas, Brazil, was obtained a reduction of 80% of the affection of Malaria with the participation of our products.

  31. Research and Development • 41 research projects are in process: • Biologic: 14 • Pharmaceutical: 15 • Chemical: 7 • Natural Products: 5 • The most outstanding are: • Vaccine for the Equine Infectious Anaemia (AIE). • AIE Diagnosis Media by PSR. • Naked DNA vaccine for the virus of the avian infectious bursitis. • Recombinant BIORAT.

  32. Staff of the Group Rec. Graduated Management Services 7% 9% Technicians 14% 27% Administ. 3% Workmen 23% Especialist 17%

  33. Qualification and SciTech Info Developing activities directed to the qualification and professional advance of the staff pointing to the increase of its level as well as to raise their scientific degree.

  34. The qualification of the technical and professional staff achieved the following results: • 6 Doctors in Science • 22 Masters in Science • 22 Diplomas • 9 Researchers • Also there are in process 3 Doctors, 24 Masters and 12 Diplomas.

  35. Awards Obtained • Quality Award. Expocaribe’96 Cuba • XXV International Quality Trophy France 1997 • XXVI International Quality Trophy France 1998 • Award to the Avian Merit of the Avian Latin American Congress Peru. 1997 • OCPI award to the creativity and technological innovation Cuba 1998 • X Gold America Award to Quality EEUU 1998 • Award in the Novelties of the Industrial Property Fair Switzerland 2000 • Biovet Award granted by the Veterinary College to the DNA Gumboro vaccine Spain 2001 • Best work in avian pathology of the XVIII Avian Latin American Congress Guatemala/2001 • International Premium Quality Alimexpo Expocuba Cuba / 2003

  36. for excellence

More Related